Dr. Baker

Dr. Baker specializes in cardiovascular biology—specifically devices and interventional technologies to prevent atherosclerosis and restenosis. His research focuses on vascular mechanotransduction, or the study of cell and tissue responses to mechanical forces. Additionally, his lab works to advance vascular drug delivery and testing of drugs to be used for vessel regrowth and heart revascularization.


  • April 2014: Adrianne Shearer receives the NSF Fellowship!

  • April 2014: Anthony Monteforte receives honorable mention for the NSF Fellowship!

  • April 2014: Anthony Montefort's work on peripheral arterial disease (PAD) features in the news of The Office of Technology Commercialization! Link

  • February 2014: Subhamoy Das's abstract "Syndecan-4 Proteoliposomes Enhance Cutaneous Wound Healing and Induce Neovascularization in Ischemic Limb in a Diabetic Hyperlipidemic Mouse" gets accepted for a talk at the Society for Biomaterials (SFB) Conference of 2014 at Denver!

  • February 2014: Dr. Baker gives a talk in Lynn W. McCraw Lecture Series on "Reenginnering Growth Factor Signaling in Ischemic Disease"!

  • February 2014: Peter Voyvodic's paper "Loss of Syndecan-1 Induces a Pro-Inflammatory Phenotype in Endothelial Cells with a Dysregulated Response to Atheroprotective Flow," is accepted to Journal of Biological Chemistry!

  • More news...


  • Research

    Vascular Biology

    Our laboratory seeks to better understand the basic pathophysiologic processes that underlie atherosclerosis, stroke and other vascular disorders.

  • Research

    Therapeutics for Peripheral and Myocardial Ischemia

    Our laboratory seeks to understand why growth factor based therapies have failed to treat ischemia in patients and seeks to create novel therapeutics to increase growth factor effectiveness in this context.

  • ResearchMechanobiology

    Our lab is developing novel devices and molecular techniques for studying how vascular cells sense and respond to mechanical forces.

  • Research

    Implanted Cardiovascular Devices

    Our group works to understand the fundamental mechanisms that control the biological response to cardiovascular devices such as endovascular stents with the ultimate goal of designing more effective interventions for cardiovascular disease.